Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance

Multiple myeloma (MM) is the second most common hematological malignancy, and despite the introduction of innovative therapies, remains an incurable disease. Identifying early and minimally or non-invasive biomarkers for predicting clinical outcomes and therapeutic responses is an active field of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Melaccio, Assunta, Reale, Antonia, Saltarella, Ilaria, Desantis, Vanessa, Lamanuzzi, Aurelia, Cicco, Sebastiano, Frassanito, Maria Antonia, Vacca, Angelo, Ria, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658666/
https://www.ncbi.nlm.nih.gov/pubmed/36362718
http://dx.doi.org/10.3390/jcm11216491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658666/
https://www.ncbi.nlm.nih.gov/pubmed/36362718
http://dx.doi.org/10.3390/jcm11216491

Ejemplares similares